Neurofeedback & qEEG Research Library
A systematic review and meta-analysis found promising reductions in PTSD symptoms following neurofeedback, while emphasizing that the trials were small and varied in population, protocol and quality.
Why this finding matters
The pooled results are encouraging for people experiencing trauma-related dysregulation, but they come from only seven varied trials. The most persuasive conclusion is that neurofeedback deserves thoughtful consideration as an adjunct—not that it replaces trauma-focused care.
Research Spotlight
7 randomized trials reviewed
- Pooled SMD −1.76
- 79.3% pooled remission in NFB groups
- 24.4% in controls
- Small heterogeneous studies
What the evidence suggests
Seven randomized controlled trials were included. The pooled standardized mean difference for PTSD symptoms was −1.76, and the reported mean remission rate was 79.3% in neurofeedback groups compared with 24.4% in control groups.
What this could mean for you
The results support further clinical discussion of neurofeedback as a possible adjunct for trauma-related dysregulation. Trauma-focused psychotherapy remains central, and treatment planning should consider safety, stability and readiness.
A careful, individualized next step
Research informs—but does not replace—individual clinical judgment. We review symptoms, diagnosis, previous treatment, medications, contraindications, functional goals and the strength of evidence for the proposed protocol. A consultation does not guarantee that treatment will be recommended.
Explore whether neurofeedback is clinically appropriate
We review stability, treatment history, goals and readiness before recommending any package or protocol.
Book a Consultation Explore the related Calgary service
Related Calgary service: Neurofeedback Calgary
Study citation
Askovic et al. Neurofeedback for post-traumatic stress disorder: systematic review and meta-analysis of clinical and neurophysiological outcomes. PMID: 37732560.
View the original record on PubMed
Educational information only. Findings from pooled research do not predict individual outcomes and may involve devices or protocols that differ from EXOMIND.